首页> 外文期刊>Journal of nursing and healthcare of chronic illness >All data on both vaccines must be considered
【24h】

All data on both vaccines must be considered

机译:必须考虑两种疫苗的所有数据

获取原文
获取原文并翻译 | 示例
           

摘要

The government chose the human papillomavirus (HPV) vaccine of GlaxoSmithKline (GSK), Cervarix, after considering protection against cancer causing HPV 16 and 18, HPV 6 and 11 (which cause genital warts), and HPV strains not included in the vaccine formulation; price; and supply. Its decision was based on a comprehensive review of published and unpublished clinical efficacy and safety data. New data from GSK included the demonstration of high protection against HPV 16 and 18 for over 6.4 years, the longest protection reported for any cervical cancer vaccine to date. The study is being extended for up to 9.5 years in a subset of women.
机译:政府考虑保护免受引起HPV 16和18,HPV 6和11(引起生殖器疣)的癌症以及未包含在疫苗制剂中的HPV菌株后,选择了Cervarix的葛兰素史克(GSK)人乳头瘤病毒(HPV)疫苗;价钱;和供应。它的决定基于对已发表和未发表的临床疗效和安全性数据的全面审查。 GSK的新数据包括对HPV 16和18的高度保护已被证明超过6.4年,这是迄今为止所有宫颈癌疫苗报道的最长保护时间。这项研究在一部分女性中被延长了长达9.5年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号